Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 11 to 20 of 248 resources

  • Capital Challenge: Tackling Hepatitis C in London
    Capital Challenge: Tackling Hepatitis C in London

    A report from The Hepatitis C Trust outlining the status of hepatitis C and service provision in London.

    Greater London Mar 2013 Reports & Research PDF
  • Charles Gore: A Call to HCV Action

    A video call to action from Charles Gore, Executive Director of the Medicines Patent Pool, and ex-CEO of The Hepatitis C Trust, President of the World Hepatitis Alliance and HCV Action steering committee member.

    UK, Rest of World 19 Nov 2013 Case study, Other Video
  • Coronavirus - harm reduction leaflet
    This two-sided leaflet from The Hepatitis C Trust notes seven ways in which people who use drugs can protect themselves and others. Services are welcome to print and distribute the leaflet.
    UK Tools & Templates PDF
  • Coronavirus: 7 steps leaflet
    A two-sided leaflet detailing the 7 steps people can take to protect themselves and others from coronavirus.
    UK Other, Tools & Templates PDF
  • Database: Secondary care prison hospital contacts for hepatitis C treatment
    This database lists the hospital contact details of secondary care lead consultants and lead nurses in England responsible for hepatitis C treatment. The database lists the detention centre to which each hospital is connected, the hospital providing treatment, and the lead consultant and lead nurse's name, email address and telephone number. It is aimed at supporting the roll-out of opt-out blood-borne virus testing currently being implemented in prisons across England.
    England 2014 Tools & Templates MS Excel
  • Delivering health and care for people who sleep rough
    Published in March 2020, this report from The King's Fund on health and care for people who sleep rough focusses on reducing barriers people face to accessing healthcare services and on commissioning appropriate services. The report argues that to improve health outcomes for people sleeping rough we need local authorities to team up with charities and community services; we need both a population health approach and a place-based approach; we need co-production with people with lived experience of sleeping rough; and we need staff working with this group to be properly recruited and supported.
    UK Reports & Research, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.
    UK, Rest of World 16 Jul 2019 Reports & Research PDF
  • Drug-related infectious diseases in Europe
    This report provides an update on infectious diseases related to drug use in Europe for the period up to June 2016. It covers the most recent data both on infectious diseases among people who inject drugs in Europe, collected with the European Monitoring Centre for Drugs and Drug Addiction Drug-related infectious diseases (DRID) indicator, and on the responses in the area. It includes highlights and new findings discussed during the DRID indicator’s annual expert meeting, held in Lisbon on 6–8 June 2016.
    Rest of World Reports & Research PDF
  • Drug-related infectious diseases in Europe: Update from the EMCDDA expert network, 2020
    This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.
    UK, Rest of World Reports & Research, Strategy & Planning PDF
  • EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
    These EASL Clinical Practice Guidelines (CPGs) are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that are approved at the time of their publication.
    UK, Rest of World 2014 Training, Reports & Research, Tools & Templates PDF

Pages